New Delhi: CNBC-TV18 has learned from sources that Reliance Industries is betting big on the pharma space and planning a major foray in that space.
The company wants a big play in the $400 billion global pharma market. Its investments in this space are seen to be higher than $1 billion over the next few years, sources say.
But Reliance has declined to comment on the issue.
Reliance Industries may begin with a big brand and company buyouts to establish visibility and will tap regulated markets like US, Europe & Japan, sources add. The company may also be looking at acquiring API facilities, they say.
“But the pharma foray may be through a standalone entity and the company may not have discovery research focus in the short term,” they add.
Comments
0 comment